CAAS Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,000	Closed	-$217K	–	787
2021 Q1	$217K	Hold	5,000	–	–	﹤0.01%	631
2020 Q4	$207K	Buy	+5,000	New	+$207K	﹤0.01%	400